SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indoco Remedies informs about revised schedule of con-call meeting

08 Nov 2022 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indoco Remedies has informed about revised schedule of the Con-Call meeting planned for Friday, November 11, 2022. 

The above information is a part of company’s filings submitted to BSE.

Indoco Remedies Share Price

239.65 8.60 (3.72%)
29-Jun-2026 11:27 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1888.00
Dr. Reddys Labs. 1407.40
Cipla 1487.60
Zydus Lifesciences 1116.00
Lupin 2399.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: